Why the study?
Cardiovascular autonomic neuropathy is an underdiagnosed risk factor for CVD in people with type 2 diabetes, but little is known about the risk factors associated with it.
Are classical cardiovascular risk factors and cardiorespiratory fitness associated with cardiovascular autonomic neuropathy in people with type 2 diabetes mellitus?
Are classical cardiovascular risk factors and cardiorespiratory fitness associated with cardiovascular autonomic neuropathy in people with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
Higher resting systolic blood pressure and lower cardiorespiratory fitness are strongly associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Background People with type 2 diabetes mellitus (DM) are at increased risk of cardiovascular disease (CVD). Cardiovascular autonomic neuropathy (CAN) is an underdiagnosed risk factor for CVD, which is prevalent among people with 2DM and can lead to CVD and CVD-related mortality. Little is known about the risk factors associated with CAN in type 2DM. Thus, the study was aimed to assess CAN using five cardiovascular autonomic reflex tests (represented by Ewing’s score) and explore the factors associated with CAN in people with type 2DM. The studied factors include traditional and serological CVD risk factors obtained from a fasting blood sample and cardiorespiratory fitness (CRF) obtained via attainment of the highest peak of volumes of O 2 (VO 2Peak ). Results Univariate analysis revealed a significant positive correlation between resting systolic blood pressure (SBP) and Ewing’s score ( r=0 .47, p= .02) and an inverse correlation between VO 2Peak and Ewing’s score ( r =−0.64, p =.001). Multivariate linear regression revealed that a significant model that included resting SBP and VO 2Peak explained 93.8% of Ewing’s score variance. Conclusion CAN was associated with two CVD parameters, including resting SBP and CRF, which may indicate the importance of controlling these two factors to prevent or reduce CAN in people with type 2DM.
No takes yet. Share an insight, caveat, or question.
Ahmad Osailan (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: